NRC Health reports results for the quarter ended September 30 - Earnings Summary

• NRC Health reported quarterly adjusted earnings of 21 cents​​ per share for the quarter ended September 30. The lone analyst forecast for the quarter was for earnings of 21 cents per share.

• Revenue was $38.40 million​; analysts expected $35.80 million.

• NRC Health's reported EPS for the quarter was 21 cents​.

• The company reported quarterly net income of $4.7 million.

• NRC Health shares had risen by 5.9% this quarter and gained 19.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advertising & marketing peer group is also "buy"

• Wall Street's median 12-month price target for NRC Health is $26.00, about 13.7% above its last closing price of $22.45

This summary was machine generated from LSEG data October 27 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)